Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Copy number variants and pharmacogenomics.

Karim Ouahchi1, Neal Lindeman, Charles Lee

  • 1Brigham and Women's Hospital, Department of Pathology, and Harvard Medical School, Boston, MA 02115, USA.

Pharmacogenomics
|December 16, 2005
PubMed
Summary

Copy number variants offer new avenues for pharmacogenomic discoveries beyond single nucleotide polymorphisms. This review explores their potential impact on drug response and disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spatial remodeling of bone marrow architecture defines tissue-state signatures of disease activity and therapeutic response in myelodysplastic neoplasms.

Leukemia·2026
Same author

Population-scale Y chromosome assemblies reveal recurrent remodeling within constrained architectures.

bioRxiv : the preprint server for biology·2026
Same author

Surgical treatment for neonates with necrotising enterocolitis in the republic of Ireland: are we just seeing patients at the tip of the iceberg?

Irish journal of medical science·2026
Same author

Non-Wilms Renal Tumours in Children: The Republic of Ireland Experience.

Children (Basel, Switzerland)·2026
Same author

EXaCT-2: an augmented and customizable oncology-focused whole exome sequencing platform.

NPJ precision oncology·2026
Same author

The power, potential of real-world data in randomized controlled trials: proceedings from a multistakeholder think tank.

Trials·2026

Area of Science:

  • Genetics
  • Pharmacogenomics
  • Genomic Variation

Background:

  • Early pharmacogenomic research centered on sequence polymorphisms in drug-metabolizing enzymes.
  • The discovery of copy number variants (CNVs) presents a novel area for pharmacogenomic exploration.
  • CNVs are increasingly recognized as significant contributors to human genetic diversity.

Purpose of the Study:

  • To review the discovery and characterization of copy number variants.
  • To explore the potential implications of CNVs in pathophysiology.
  • To speculate on the future role of CNVs in pharmacogenomics.

Main Methods:

  • Literature review of studies on copy number variants.
  • Analysis of existing data on genomic variation.
  • Synthesis of current understanding of CNVs and their functional impact.

Main Results:

  • Copy number variants are widespread in the human genome.
  • CNVs represent a significant source of genetic variation beyond single nucleotide polymorphisms.
  • The discovery of CNVs opens new possibilities for personalized medicine.

Conclusions:

  • Copy number variants are a promising frontier for pharmacogenomic research.
  • Understanding CNVs may lead to improved prediction of drug efficacy and toxicity.
  • CNVs could offer new insights into disease mechanisms and therapeutic targets.

Related Experiment Videos